Selected Abstracts from the 2023 CROI Conference
Discussion of use of LAI ART for persons with…
Considerations in recommending aspirin for PWH
Opportunistic infections and ART guidelines…
Review of the DAWNING trial and the NADIA trial
Rationale and results of the DoxyPEP study /…
Review of the changes to the IAS-USA guidelines…
Injectable ART for those with detectable viral…
Diagnosis and Management of Substance-Induced…
Considerations in primary care for patients using…
Data on the newly approved medication Lenacapavir
HIV Treatment Guidelines
Review of historic and recent data on…
NAAT HIV testing for patients on PrEP
Review of comorbidity studies presented at the…
Guidelines and considerations for prevention…
Update on long-acting Cabotegravir asPrEP,…
Assessing cardiovascular risk and treatment for…